Medscape Medical NewsAll articles

LensHooke X1 PRO Semen Quality Analyzer, LensHooke X1 PRO SE Semen Quality Analyzer

Bonraybio Co., Ltd. • Hematology • 10/28/2020

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The LensHooke X1 PRO and X1 PRO SE Semen Quality Analyzers are optical devices that employ image analysis and artificial intelligence to provide quantitative measurements of key semen parameters, including sperm concentration, motility, morphology, and pH, for male fertility assessment. These systems are designed for use with a specific test cassette, with the X1 PRO version for professional point-of-care settings and the X1 PRO SE for over-the-counter home use.

Summary

The LensHooke X1 PRO and X1 PRO SE Semen Quality Analyzers are optical in-vitro diagnostic devices designed for human semen analysis to evaluate male fertility. They provide quantitative measurements for sperm concentration (10^6 per ml), total motility (%), sperm morphology (normal forms, %), and pH value. The X1 PRO model, intended for healthcare professional settings, additionally differentiates between progressive and non-progressive motility. Both systems utilize the LensHooke Semen Test Cassette, a specialized microscopic slide, and operate by integrating optical design with image analysis and artificial intelligence image processing. The analyzers capture images via cameras; sperm concentration is determined by sperm unit density, motility by tracing sperm trajectories, and morphology by comparing head and tail percentages, while pH is assessed through chromatographic image analysis of pH paper. The systems include consumables such as the test cassette, quality control beads and reticles (LensHooke X QC Beads and Reticle), a liquefaction test cup (C-KUP), and cleaning wipes. Non-clinical testing evaluated repeatability, reproducibility, limit of blank/detection/quantitation, linearity, sample volume, operating conditions, and stability. Clinical studies included a system accuracy study and a lay-user performance study for the X1 PRO SE (over-the-counter model), which demonstrated that lay users could understand instructions and obtain accurate results compared to a reference method (SQA-V Analyzer) used by professionals. The devices are presented as tools for fertility evaluation but do not provide a comprehensive assessment of male fertility status; the X1 PRO SE is specified for single-person home use.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

semen analysismale fertilitysperm concentrationsperm motilitysperm morphologypH valueoptical analysisimage processingartificial intelligencein-vitro diagnostic

Device Metadata

Submission Number
K202089
Company
Bonraybio Co., Ltd.
Panel
Hematology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. What are the specific Limits of Blank (LoB), Detection (LoD), and Quantitation (LoQ) for sperm concentration, motility percentages, morphology percentage, and pH value?; How does the artificial intelligence image processing algorithm differentiate between normal and abnormal sperm morphology, and what are its criteria for head and tail percentages?; What were the quantitative results and statistical significance of the repeatability and reproducibility studies across different operators and device units?; Can the device differentiate between progressive and non-progressive motility accurately in samples with very low or very high sperm concentrations?; How does the device's performance in lay-user hands for the X1 PRO SE model compare to results obtained by trained professionals using the X1 PRO model or the SQA-V reference method, particularly in terms of accuracy and precision for each parameter?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials(camera)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, HBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
LensHooke X1 PRO Semen Quality Analyzer, LensHooke X1 PRO SE Semen Quality Analyzer - Bonraybio Co., Ltd. | ESL FDA AI Device Intelligence